View in EDS

Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease.

Saved in:
Bibliographic Details
Title: Downregulation of PHGDH expression and hepatic serine level contribute to the development of fatty liver disease.
Authors: Sim WC; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Lee W; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Sim H; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Lee KY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Jung SH; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Choi YJ; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Kim HY; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Kang KW; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea., Lee JY; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea., Choi YJ; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea., Kim SK; College of Pharmacy, Chungnam National University, Daejeon, Republic of Korea., Jun DW; Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea., Kim W; Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Republic of Korea., Lee BH; College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Republic of Korea. Electronic address: lee@snu.ac.kr.
Source: Metabolism: clinical and experimental [Metabolism] 2020 Jan; Vol. 102, pp. 154000. Date of Electronic Publication: 2019 Oct 31.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 0375267 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8600 (Electronic) Linking ISSN: 00260495 NLM ISO Abbreviation: Metabolism Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-8600
DOI:10.1016/j.metabol.2019.154000